(Q37925631)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

0 references

1 reference

title

Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

0 references

0 references

magnetic resonance imaging

0 references

author

Shengming Deng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Hui-Lin Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Tao Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Xi-Ming Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Yong Xu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

0 references

publication date

2 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

2604-2617

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

Bone imaging in metastatic breast cancer

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Advanced methods in meta-analysis: multivariate approach and meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Meta-DiSc: a software for meta-analysis of test accuracy data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection--pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

99mTc depreotide scan compared with 99mTc-MDP bone scintigraphy for the detection of bone metastases and prediction of response to hormonal treatment in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Whole-body MR imaging: evaluation of patients for metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

A new computer-based decision-support system for the interpretation of bone scans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

[18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Detection of bone metastases in thyroid cancer patients: bone scintigraphy or 18F-FDG PET?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Detection of bone metastases: assessment of integrated FDG PET/CT imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Quality of planar whole-body bone scan interpretations--a nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Bone metastasis in patients with non-small cell lung cancer: the diagnostic role of F-18 FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

"One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Empirical evidence of design-related bias in studies of diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Conditional logistic regression with sandwich estimators: application to a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Comparison of 18F-FDG PET and Bone Scintigraphy in Detection of Bone Metastases of Thyroid Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Publications on diagnostic test evaluation in family medicine journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-011-2221-4

The role of positron emission tomography in the management of bone metastases

21 January 2018

1 reference

12 December 2020

Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy

1 reference

12 December 2020

Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer

1 reference

12 December 2020

Radiological imaging for the diagnosis of bone metastases.

1 reference

12 December 2020

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

12 December 2020

Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.

1 reference

12 December 2020

Is there a "best" way to detect and minimize publication bias? An empirical evaluation

1 reference

12 December 2020

Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer

1 reference

12 December 2020

Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer

1 reference

12 December 2020

Biology of osteoclast activation in cancer

1 reference

12 December 2020

Value of routine 99mTc-MDP bone scintigraphy in the detection of occult skeletal metastases in women with primary breast cancer

1 reference

12 December 2020

2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial

1 reference

12 December 2020

Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management

1 reference

12 December 2020

Bone scintigraphy of skeletal metastasis in hepatoma patients treated by TAE.

1 reference

12 December 2020

FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma

1 reference

12 December 2020

[Diagnostic value of nuclide bone imaging for bone metastasis from lung cancer and clinic analysis]

1 reference

12 December 2020

Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer

1 reference

12 December 2020

The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

1 reference

12 December 2020

Single photon emission computed tomography/spiral computed tomography fusion imaging for the diagnosis of bone metastasis in patients with known cancer

1 reference

12 December 2020

Limitations of Bone Scanning In Clinical Oncology

1 reference

12 December 2020

A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations

1 reference

12 December 2020

The diagnostic value of bone scan in patients with renal cell carcinoma

1 reference

12 December 2020

Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities

1 reference

12 December 2020

A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases

1 reference

12 December 2020

Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET

1 reference

12 December 2020

Metastases seen on SPECT imaging despite a normal planar bone scan

1 reference

12 December 2020

Current imaging in spinal metastatic disease

1 reference

12 December 2020

Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.

1 reference

12 December 2020

Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET

1 reference

12 December 2020

Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions

1 reference

12 December 2020

Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography

1 reference

12 December 2020

The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine

1 reference

12 December 2020

The role of computed tomography in the detection of bone metastases in breast cancer patients

1 reference

12 December 2020

The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer

1 reference

12 December 2020

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

12 December 2020

Bone metastases--the clinical problem

1 reference

12 December 2020

Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.

1 reference

12 December 2020

A bivariate approach to meta-analysis

1 reference

12 December 2020

Feasibility of whole body diffusion weighted imaging in detecting bone metastasis on 3.0T MR scanner

1 reference

12 December 2020

Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective study.

1 reference

12 December 2020

Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma

1 reference

12 December 2020

Computed tomography in detecting bone metastases of breast carcinoma. Is it better than plain x-ray?

1 reference

12 December 2020

Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer

1 reference

12 December 2020

10.1007/S00330-011-2221-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21887484%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference